Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Verizon
VZ
|
$2.78B |
| 2 |
Apple
AAPL
|
$1.6B |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$851M |
| 4 |
BHI
Baker Hughes
BHI
|
$743M |
| 5 |
Texas Instruments
TXN
|
$716M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$960M |
| 2 |
ENDP
Endo International plc
ENDP
|
$949M |
| 3 |
Microsoft
MSFT
|
$942M |
| 4 |
Gilead Sciences
GILD
|
$934M |
| 5 |
UnitedHealth
UNH
|
$836M |
Sector Composition
| 1 | Healthcare | 20.71% |
| 2 | Technology | 12.9% |
| 3 | Communication Services | 11.29% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Discretionary | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $10.2B | 3.68% | 82,521,399 +5,088,939 | +7% | +$628M |
|
|
2
Gilead Sciences
GILD
$140B
| $8.71B | 3.15% | 122,891,424 -13,175,846 | -10% | -$934M |
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $7.76B | 2.8% | 6,962,401 -174,696 | -2% | -$195M |
|
|
4
Verizon
VZ
$186B
| $7.5B | 2.71% | 157,677,745 +58,459,585 | +59% | +$2.78B |
|
5
Philip Morris
PM
$260B
| $7.39B | 2.67% | 90,213,019 -7,357,963 | -8% | -$602M |
|
6
Oracle
ORCL
$635B
| $6.42B | 2.32% | 156,892,184 +3,342,853 | +2% | +$137M |
|
7
Altria Group
MO
$113B
| $5.68B | 2.05% | 151,838,928 +4,698,293 | +3% | +$176M |
|
|
8
Texas Instruments
TXN
$184B
| $5.35B | 1.93% | 113,477,361 +15,182,389 | +15% | +$716M |
|
9
AbbVie
ABBV
$372B
| $5.24B | 1.89% | 101,923,389 +1,961,264 | +2% | +$101M |
|
10
Amazon
AMZN
$2.44T
| $4.99B | 1.8% | 14,826,470 +478,580 | +3% | +$161M |
|
11
General Dynamics
GD
$87.3B
| $3.89B | 1.4% | 35,674,538 +121,559 | +0.3% | +$13.2M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.57B | 1.29% | 23,484,473 -218,639 | -0.9% | -$33.3M |
|
|
13
Apple
AAPL
$3.45T
| $3.36B | 1.21% | 6,260,965 +2,978,975 | +91% | +$1.6B |
|
14
EOG Resources
EOG
$68.2B
| $3.34B | 1.21% | 17,038,362 -886,132 | -5% | -$174M |
|
15
Home Depot
HD
$405B
| $3.15B | 1.14% | 39,819,007 -3,577,833 | -8% | -$283M |
|
16
Union Pacific
UNP
$133B
| $2.77B | 1% | 14,775,856 -77,701 | -0.5% | -$14.6M |
|
17
Biogen
BIIB
$19.4B
| $2.61B | 0.94% | 8,543,550 -613,450 | -7% | -$188M |
|
18
Exelon
EXC
$44.1B
| $2.58B | 0.93% | 76,926,421 +824,741 | +1% | +$27.7M |
|
19
Accenture
ACN
$162B
| $2.54B | 0.92% | 31,900,597 +601,777 | +2% | +$48M |
|
20
Schlumberger
SLB
$55B
| $2.51B | 0.91% | 25,780,899 -5,962,190 | -19% | -$581M |
|
|
21
Microsoft
MSFT
$3.77T
| $2.51B | 0.91% | 61,254,873 -22,972,287 | -27% | -$942M |
|
|
BHI
22
DELISTED
Baker Hughes
BHI
| $2.48B | 0.9% | 38,128,993 +11,421,493 | +43% | +$743M |
|
23
CSX Corp
CSX
$60.6B
| $2.47B | 0.89% | 85,401,502 -2,314,549 | -3% | -$67.1M |
|
24
Lumen
LUMN
$5.1B
| $2.38B | 0.86% | 72,406,172 | – | – |
|
|
AGN
25
DELISTED
ALLERGAN INC
AGN
| $2.33B | 0.84% | 18,794,109 +1,321,576 | +8% | +$164M |
|